nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Vinca Alkaloids—Vinblastine—breast cancer	0.233	1	CiPCiCtD
Vinorelbine—Vinblastine—breast cancer	0.174	1	CrCtD
Vinorelbine—ovarian cancer—breast cancer	0.142	1	CtDrD
Vinorelbine—TUBB3—breast cancer	0.0612	0.684	CbGaD
Vinorelbine—Vincristine—Vinblastine—breast cancer	0.0405	0.379	CrCrCtD
Vinorelbine—Vindesine—Vinblastine—breast cancer	0.0405	0.379	CrCrCtD
Vinorelbine—Voacamine—Vinblastine—breast cancer	0.0259	0.242	CrCrCtD
Vinorelbine—CYP2D6—breast cancer	0.011	0.123	CbGaD
Vinorelbine—CYP3A4—breast cancer	0.00942	0.105	CbGaD
Vinorelbine—ABCB1—breast cancer	0.00784	0.0877	CbGaD
Vinorelbine—TUBB6—Eribulin—breast cancer	0.0073	0.0392	CbGbCtD
Vinorelbine—TUBB8—Eribulin—breast cancer	0.0073	0.0392	CbGbCtD
Vinorelbine—TUBB2B—Eribulin—breast cancer	0.0073	0.0392	CbGbCtD
Vinorelbine—TUBB4A—Eribulin—breast cancer	0.0073	0.0392	CbGbCtD
Vinorelbine—TUBB3—Eribulin—breast cancer	0.0073	0.0392	CbGbCtD
Vinorelbine—TUBB2A—Eribulin—breast cancer	0.0073	0.0392	CbGbCtD
Vinorelbine—TUBB2B—Ixabepilone—breast cancer	0.007	0.0376	CbGbCtD
Vinorelbine—TUBB8—Ixabepilone—breast cancer	0.007	0.0376	CbGbCtD
Vinorelbine—TUBB4A—Ixabepilone—breast cancer	0.007	0.0376	CbGbCtD
Vinorelbine—TUBB3—Ixabepilone—breast cancer	0.007	0.0376	CbGbCtD
Vinorelbine—TUBB2A—Ixabepilone—breast cancer	0.007	0.0376	CbGbCtD
Vinorelbine—TUBB6—Ixabepilone—breast cancer	0.007	0.0376	CbGbCtD
Vinorelbine—TUBB1—Eribulin—breast cancer	0.00611	0.0328	CbGbCtD
Vinorelbine—TUBB4B—Eribulin—breast cancer	0.00611	0.0328	CbGbCtD
Vinorelbine—TUBB—Eribulin—breast cancer	0.00611	0.0328	CbGbCtD
Vinorelbine—TUBB4B—Ixabepilone—breast cancer	0.00586	0.0314	CbGbCtD
Vinorelbine—TUBB—Ixabepilone—breast cancer	0.00586	0.0314	CbGbCtD
Vinorelbine—TUBB1—Ixabepilone—breast cancer	0.00586	0.0314	CbGbCtD
Vinorelbine—TUBB8—Paclitaxel—breast cancer	0.00263	0.0141	CbGbCtD
Vinorelbine—TUBB2A—Paclitaxel—breast cancer	0.00263	0.0141	CbGbCtD
Vinorelbine—TUBB6—Paclitaxel—breast cancer	0.00263	0.0141	CbGbCtD
Vinorelbine—TUBB3—Paclitaxel—breast cancer	0.00263	0.0141	CbGbCtD
Vinorelbine—TUBB2B—Paclitaxel—breast cancer	0.00263	0.0141	CbGbCtD
Vinorelbine—TUBB4A—Paclitaxel—breast cancer	0.00263	0.0141	CbGbCtD
Vinorelbine—TUBB6—Vinblastine—breast cancer	0.0023	0.0124	CbGbCtD
Vinorelbine—TUBB8—Vinblastine—breast cancer	0.0023	0.0124	CbGbCtD
Vinorelbine—TUBB2B—Vinblastine—breast cancer	0.0023	0.0124	CbGbCtD
Vinorelbine—TUBB4A—Vinblastine—breast cancer	0.0023	0.0124	CbGbCtD
Vinorelbine—TUBB3—Vinblastine—breast cancer	0.0023	0.0124	CbGbCtD
Vinorelbine—TUBB2A—Vinblastine—breast cancer	0.0023	0.0124	CbGbCtD
Vinorelbine—TUBB—Paclitaxel—breast cancer	0.0022	0.0118	CbGbCtD
Vinorelbine—TUBB4B—Paclitaxel—breast cancer	0.0022	0.0118	CbGbCtD
Vinorelbine—TUBB1—Paclitaxel—breast cancer	0.0022	0.0118	CbGbCtD
Vinorelbine—TUBB1—Vinblastine—breast cancer	0.00193	0.0103	CbGbCtD
Vinorelbine—TUBB4B—Vinblastine—breast cancer	0.00193	0.0103	CbGbCtD
Vinorelbine—TUBB—Vinblastine—breast cancer	0.00193	0.0103	CbGbCtD
Vinorelbine—TUBB3—Docetaxel—breast cancer	0.0019	0.0102	CbGbCtD
Vinorelbine—TUBB2B—Docetaxel—breast cancer	0.0019	0.0102	CbGbCtD
Vinorelbine—TUBB4A—Docetaxel—breast cancer	0.0019	0.0102	CbGbCtD
Vinorelbine—TUBB8—Docetaxel—breast cancer	0.0019	0.0102	CbGbCtD
Vinorelbine—TUBB6—Docetaxel—breast cancer	0.0019	0.0102	CbGbCtD
Vinorelbine—TUBB2A—Docetaxel—breast cancer	0.0019	0.0102	CbGbCtD
Vinorelbine—TUBB1—Docetaxel—breast cancer	0.00159	0.00853	CbGbCtD
Vinorelbine—TUBB4B—Docetaxel—breast cancer	0.00159	0.00853	CbGbCtD
Vinorelbine—TUBB—Docetaxel—breast cancer	0.00159	0.00853	CbGbCtD
Vinorelbine—ABCB1—Toremifene—breast cancer	0.00055	0.00295	CbGbCtD
Vinorelbine—CYP3A4—Exemestane—breast cancer	0.000475	0.00255	CbGbCtD
Vinorelbine—CYP2D6—Idarubicin—breast cancer	0.000429	0.0023	CbGbCtD
Vinorelbine—CYP3A4—Letrozole—breast cancer	0.000404	0.00217	CbGbCtD
Vinorelbine—ABCB1—Lapatinib—breast cancer	0.000401	0.00215	CbGbCtD
Vinorelbine—CYP3A4—Anastrozole—breast cancer	0.00036	0.00193	CbGbCtD
Vinorelbine—CYP3A4—Toremifene—breast cancer	0.000329	0.00177	CbGbCtD
Vinorelbine—CYP3A4—Fulvestrant—breast cancer	0.000306	0.00164	CbGbCtD
Vinorelbine—CYP3A4—Thiotepa—breast cancer	0.000273	0.00147	CbGbCtD
Vinorelbine—TUBB6—mammary gland—breast cancer	0.000258	0.029	CbGeAlD
Vinorelbine—CYP3A4—Ixabepilone—breast cancer	0.00025	0.00134	CbGbCtD
Vinorelbine—CYP3A4—Lapatinib—breast cancer	0.00024	0.00129	CbGbCtD
Vinorelbine—TUBB2B—nipple—breast cancer	0.00023	0.0259	CbGeAlD
Vinorelbine—TUBB4B—mammary gland—breast cancer	0.000224	0.0252	CbGeAlD
Vinorelbine—TUBB—nipple—breast cancer	0.000217	0.0245	CbGeAlD
Vinorelbine—TUBB2A—nipple—breast cancer	0.000216	0.0243	CbGeAlD
Vinorelbine—TUBB6—nipple—breast cancer	0.000213	0.024	CbGeAlD
Vinorelbine—TUBB1—adipose tissue—breast cancer	0.000208	0.0234	CbGeAlD
Vinorelbine—ABCB1—Tamoxifen—breast cancer	0.000201	0.00108	CbGbCtD
Vinorelbine—TUBB4A—embryo—breast cancer	0.000196	0.0221	CbGeAlD
Vinorelbine—ABCB1—Mitoxantrone—breast cancer	0.000196	0.00105	CbGbCtD
Vinorelbine—CYP2D6—Tamoxifen—breast cancer	0.000189	0.00102	CbGbCtD
Vinorelbine—TUBB4B—nipple—breast cancer	0.000185	0.0209	CbGeAlD
Vinorelbine—CYP3A4—Raloxifene—breast cancer	0.000182	0.000978	CbGbCtD
Vinorelbine—TUBB1—bone marrow—breast cancer	0.00018	0.0203	CbGeAlD
Vinorelbine—ABCB1—Gemcitabine—breast cancer	0.000173	0.000929	CbGbCtD
Vinorelbine—ABCB1—Paclitaxel—breast cancer	0.000156	0.000839	CbGbCtD
Vinorelbine—ABCB1—Irinotecan—breast cancer	0.000154	0.000828	CbGbCtD
Vinorelbine—TUBB4B—embryo—breast cancer	0.000153	0.0172	CbGeAlD
Vinorelbine—TUBB4A—skin of body—breast cancer	0.000152	0.0171	CbGeAlD
Vinorelbine—TUBB6—epithelium—breast cancer	0.000144	0.0162	CbGeAlD
Vinorelbine—Vinblastine—TUBB3—breast cancer	0.000139	0.17	CrCbGaD
Vinorelbine—TUBB2B—endometrium—breast cancer	0.000139	0.0156	CbGeAlD
Vinorelbine—TUBB2A—skin of body—breast cancer	0.000139	0.0156	CbGeAlD
Vinorelbine—ABCB1—Vinblastine—breast cancer	0.000137	0.000736	CbGbCtD
Vinorelbine—TUBB6—skin of body—breast cancer	0.000137	0.0154	CbGeAlD
Vinorelbine—Vincristine—TUBB3—breast cancer	0.000136	0.168	CrCbGaD
Vinorelbine—TUBB4A—uterus—breast cancer	0.000132	0.0149	CbGeAlD
Vinorelbine—TUBB—endometrium—breast cancer	0.000131	0.0148	CbGeAlD
Vinorelbine—TUBB2A—endometrium—breast cancer	0.000131	0.0147	CbGeAlD
Vinorelbine—TUBB6—Zalcitabine—Gemcitabine—breast cancer	0.00013	0.298	CbGdCrCtD
Vinorelbine—CYP2D6—Vinblastine—breast cancer	0.000129	0.000694	CbGbCtD
Vinorelbine—TUBB6—endometrium—breast cancer	0.000129	0.0145	CbGeAlD
Vinorelbine—Vinblastine—JUN—breast cancer	0.000127	0.156	CrCbGaD
Vinorelbine—TUBB2B—pituitary gland—breast cancer	0.000126	0.0141	CbGeAlD
Vinorelbine—TUBB2B—adipose tissue—breast cancer	0.000125	0.0141	CbGeAlD
Vinorelbine—TUBB—uterus—breast cancer	0.000121	0.0136	CbGeAlD
Vinorelbine—CYP3A4—Tamoxifen—breast cancer	0.00012	0.000646	CbGbCtD
Vinorelbine—TUBB2A—uterus—breast cancer	0.00012	0.0135	CbGeAlD
Vinorelbine—TUBB4A—female reproductive system—breast cancer	0.000119	0.0134	CbGeAlD
Vinorelbine—TUBB—pituitary gland—breast cancer	0.000119	0.0134	CbGeAlD
Vinorelbine—TUBB4B—skin of body—breast cancer	0.000119	0.0134	CbGeAlD
Vinorelbine—TUBB6—uterus—breast cancer	0.000119	0.0134	CbGeAlD
Vinorelbine—TUBB—adipose tissue—breast cancer	0.000118	0.0133	CbGeAlD
Vinorelbine—TUBB2A—pituitary gland—breast cancer	0.000118	0.0133	CbGeAlD
Vinorelbine—TUBB2A—adipose tissue—breast cancer	0.000118	0.0132	CbGeAlD
Vinorelbine—CYP3A4—Mitoxantrone—breast cancer	0.000117	0.00063	CbGbCtD
Vinorelbine—TUBB6—pituitary gland—breast cancer	0.000117	0.0131	CbGeAlD
Vinorelbine—TUBB6—adipose tissue—breast cancer	0.000116	0.0131	CbGeAlD
Vinorelbine—TUBB4A—adrenal gland—breast cancer	0.000116	0.0131	CbGeAlD
Vinorelbine—TUBB2B—female reproductive system—breast cancer	0.000115	0.0129	CbGeAlD
Vinorelbine—ABCB1—Docetaxel—breast cancer	0.000113	0.000607	CbGbCtD
Vinorelbine—TUBB2B—adrenal gland—breast cancer	0.000112	0.0126	CbGeAlD
Vinorelbine—TUBB4B—endometrium—breast cancer	0.000112	0.0126	CbGeAlD
Vinorelbine—TUBB4A—female gonad—breast cancer	0.000108	0.0122	CbGeAlD
Vinorelbine—TUBB2A—female reproductive system—breast cancer	0.000108	0.0122	CbGeAlD
Vinorelbine—TUBB6—female reproductive system—breast cancer	0.000107	0.012	CbGeAlD
Vinorelbine—TUBB—adrenal gland—breast cancer	0.000106	0.0119	CbGeAlD
Vinorelbine—TUBB2A—adrenal gland—breast cancer	0.000106	0.0119	CbGeAlD
Vinorelbine—TUBB2B—female gonad—breast cancer	0.000105	0.0118	CbGeAlD
Vinorelbine—TUBB6—adrenal gland—breast cancer	0.000104	0.0117	CbGeAlD
Vinorelbine—TUBB4B—uterus—breast cancer	0.000103	0.0116	CbGeAlD
Vinorelbine—TUBB—bone marrow—breast cancer	0.000103	0.0116	CbGeAlD
Vinorelbine—TUBB2A—bone marrow—breast cancer	0.000102	0.0115	CbGeAlD
Vinorelbine—TUBB4B—pituitary gland—breast cancer	0.000101	0.0114	CbGeAlD
Vinorelbine—TUBB4B—adipose tissue—breast cancer	0.000101	0.0114	CbGeAlD
Vinorelbine—TUBB6—bone marrow—breast cancer	0.000101	0.0113	CbGeAlD
Vinorelbine—TUBB4A—endocrine gland—breast cancer	0.000101	0.0113	CbGeAlD
Vinorelbine—TUBB—female gonad—breast cancer	9.9e-05	0.0111	CbGeAlD
Vinorelbine—TUBB2A—female gonad—breast cancer	9.84e-05	0.0111	CbGeAlD
Vinorelbine—TUBB2B—endocrine gland—breast cancer	9.72e-05	0.0109	CbGeAlD
Vinorelbine—TUBB6—female gonad—breast cancer	9.71e-05	0.0109	CbGeAlD
Vinorelbine—CYP3A4—Paclitaxel—breast cancer	9.37e-05	0.000503	CbGbCtD
Vinorelbine—TUBB4B—female reproductive system—breast cancer	9.27e-05	0.0104	CbGeAlD
Vinorelbine—CYP3A4—Irinotecan—breast cancer	9.24e-05	0.000496	CbGbCtD
Vinorelbine—TUBB2A—endocrine gland—breast cancer	9.15e-05	0.0103	CbGeAlD
Vinorelbine—TUBB4B—adrenal gland—breast cancer	9.05e-05	0.0102	CbGeAlD
Vinorelbine—TUBB6—endocrine gland—breast cancer	9.03e-05	0.0102	CbGeAlD
Vinorelbine—TUBB4B—bone marrow—breast cancer	8.76e-05	0.00986	CbGeAlD
Vinorelbine—TUBB4B—female gonad—breast cancer	8.44e-05	0.0095	CbGeAlD
Vinorelbine—ABCB1—Doxorubicin—breast cancer	8.43e-05	0.000452	CbGbCtD
Vinorelbine—CYP3A4—Vinblastine—breast cancer	8.22e-05	0.000441	CbGbCtD
Vinorelbine—ABCB1—Methotrexate—breast cancer	8.16e-05	0.000438	CbGbCtD
Vinorelbine—Vinblastine—ABCC1—breast cancer	8.11e-05	0.0996	CrCbGaD
Vinorelbine—Vincristine—ABCC1—breast cancer	7.97e-05	0.0979	CrCbGaD
Vinorelbine—CYP2D6—Doxorubicin—breast cancer	7.94e-05	0.000426	CbGbCtD
Vinorelbine—TUBB4B—endocrine gland—breast cancer	7.85e-05	0.00883	CbGeAlD
Vinorelbine—TUBB6—Clomifene—Toremifene—breast cancer	7.4e-05	0.169	CbGdCrCtD
Vinorelbine—TUBB4A—lymph node—breast cancer	6.96e-05	0.00783	CbGeAlD
Vinorelbine—CYP3A4—Docetaxel—breast cancer	6.77e-05	0.000364	CbGbCtD
Vinorelbine—TUBB2B—lymph node—breast cancer	6.72e-05	0.00757	CbGeAlD
Vinorelbine—TUBB—Azacitidine—Gemcitabine—breast cancer	6.64e-05	0.152	CbGdCrCtD
Vinorelbine—TUBB—lymph node—breast cancer	6.36e-05	0.00716	CbGeAlD
Vinorelbine—TUBB2A—lymph node—breast cancer	6.33e-05	0.00712	CbGeAlD
Vinorelbine—TUBB6—lymph node—breast cancer	6.24e-05	0.00703	CbGeAlD
Vinorelbine—Vindesine—CYP3A4—breast cancer	5.68e-05	0.0697	CrCbGaD
Vinorelbine—TUBB4B—lymph node—breast cancer	5.43e-05	0.00611	CbGeAlD
Vinorelbine—CYP3A4—Doxorubicin—breast cancer	5.05e-05	0.000271	CbGbCtD
Vinorelbine—Voacamine—ABCB1—breast cancer	4.99e-05	0.0612	CrCbGaD
Vinorelbine—TUBB6—Tamoxifen—Toremifene—breast cancer	4.75e-05	0.109	CbGdCrCtD
Vinorelbine—TUBB6—Clomifene—Tamoxifen—breast cancer	4.65e-05	0.106	CbGdCrCtD
Vinorelbine—TUBB6—Toremifene—Tamoxifen—breast cancer	4.54e-05	0.104	CbGdCrCtD
Vinorelbine—ABCB1—embryo—breast cancer	4.45e-05	0.00501	CbGeAlD
Vinorelbine—Vincristine—ABCG2—breast cancer	4.2e-05	0.0516	CrCbGaD
Vinorelbine—CYP3A4—female reproductive system—breast cancer	3.81e-05	0.00429	CbGeAlD
Vinorelbine—CYP2D6—female reproductive system—breast cancer	3.75e-05	0.00422	CbGeAlD
Vinorelbine—ABCB1—epithelium—breast cancer	3.63e-05	0.00409	CbGeAlD
Vinorelbine—CYP2D6—female gonad—breast cancer	3.41e-05	0.00384	CbGeAlD
Vinorelbine—ABCB1—endometrium—breast cancer	3.26e-05	0.00367	CbGeAlD
Vinorelbine—CYP3A4—endocrine gland—breast cancer	3.22e-05	0.00363	CbGeAlD
Vinorelbine—CYP2D6—endocrine gland—breast cancer	3.17e-05	0.00357	CbGeAlD
Vinorelbine—ABCB1—uterus—breast cancer	3e-05	0.00338	CbGeAlD
Vinorelbine—ABCB1—pituitary gland—breast cancer	2.95e-05	0.00332	CbGeAlD
Vinorelbine—ABCB1—adipose tissue—breast cancer	2.93e-05	0.0033	CbGeAlD
Vinorelbine—TUBB6—Azacitidine—Gemcitabine—breast cancer	2.74e-05	0.0627	CbGdCrCtD
Vinorelbine—ABCB1—female reproductive system—breast cancer	2.7e-05	0.00304	CbGeAlD
Vinorelbine—ABCB1—adrenal gland—breast cancer	2.63e-05	0.00296	CbGeAlD
Vinorelbine—ABCB1—bone marrow—breast cancer	2.55e-05	0.00287	CbGeAlD
Vinorelbine—Vinblastine—CYP2D6—breast cancer	2.49e-05	0.0306	CrCbGaD
Vinorelbine—ABCB1—female gonad—breast cancer	2.45e-05	0.00276	CbGeAlD
Vinorelbine—ABCB1—endocrine gland—breast cancer	2.28e-05	0.00257	CbGeAlD
Vinorelbine—Vinblastine—CYP3A4—breast cancer	2.14e-05	0.0263	CrCbGaD
Vinorelbine—Vincristine—CYP3A4—breast cancer	2.1e-05	0.0258	CrCbGaD
Vinorelbine—Vinblastine—ABCB1—breast cancer	1.78e-05	0.0219	CrCbGaD
Vinorelbine—Vincristine—ABCB1—breast cancer	1.75e-05	0.0215	CrCbGaD
Vinorelbine—ABCB1—lymph node—breast cancer	1.58e-05	0.00178	CbGeAlD
Vinorelbine—Anorexia—Docetaxel—breast cancer	5.47e-06	0.000143	CcSEcCtD
Vinorelbine—Nervous system disorder—Capecitabine—breast cancer	5.45e-06	0.000142	CcSEcCtD
Vinorelbine—Diarrhoea—Fluorouracil—breast cancer	5.44e-06	0.000142	CcSEcCtD
Vinorelbine—Thrombocytopenia—Capecitabine—breast cancer	5.44e-06	0.000142	CcSEcCtD
Vinorelbine—Tachycardia—Capecitabine—breast cancer	5.42e-06	0.000141	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—breast cancer	5.42e-06	0.000141	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—breast cancer	5.4e-06	0.000141	CcSEcCtD
Vinorelbine—Skin disorder—Capecitabine—breast cancer	5.4e-06	0.000141	CcSEcCtD
Vinorelbine—Urticaria—Paclitaxel—breast cancer	5.38e-06	0.00014	CcSEcCtD
Vinorelbine—Hypotension—Docetaxel—breast cancer	5.36e-06	0.00014	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—breast cancer	5.35e-06	0.00014	CcSEcCtD
Vinorelbine—Abdominal pain—Paclitaxel—breast cancer	5.35e-06	0.00014	CcSEcCtD
Vinorelbine—Body temperature increased—Paclitaxel—breast cancer	5.35e-06	0.00014	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—breast cancer	5.31e-06	0.000139	CcSEcCtD
Vinorelbine—Anorexia—Capecitabine—breast cancer	5.3e-06	0.000138	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—breast cancer	5.28e-06	0.000138	CcSEcCtD
Vinorelbine—Vomiting—Mitoxantrone—breast cancer	5.28e-06	0.000138	CcSEcCtD
Vinorelbine—Vomiting—Irinotecan—breast cancer	5.28e-06	0.000138	CcSEcCtD
Vinorelbine—Immune system disorder—Methotrexate—breast cancer	5.26e-06	0.000137	CcSEcCtD
Vinorelbine—Dizziness—Fluorouracil—breast cancer	5.26e-06	0.000137	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—breast cancer	5.25e-06	0.000137	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—breast cancer	5.24e-06	0.000137	CcSEcCtD
Vinorelbine—Rash—Irinotecan—breast cancer	5.23e-06	0.000137	CcSEcCtD
Vinorelbine—Rash—Mitoxantrone—breast cancer	5.23e-06	0.000137	CcSEcCtD
Vinorelbine—Dermatitis—Mitoxantrone—breast cancer	5.23e-06	0.000136	CcSEcCtD
Vinorelbine—Dermatitis—Irinotecan—breast cancer	5.23e-06	0.000136	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Docetaxel—breast cancer	5.23e-06	0.000136	CcSEcCtD
Vinorelbine—Headache—Irinotecan—breast cancer	5.2e-06	0.000136	CcSEcCtD
Vinorelbine—Headache—Mitoxantrone—breast cancer	5.2e-06	0.000136	CcSEcCtD
Vinorelbine—Hypotension—Capecitabine—breast cancer	5.19e-06	0.000135	CcSEcCtD
Vinorelbine—Paraesthesia—Docetaxel—breast cancer	5.15e-06	0.000134	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—breast cancer	5.15e-06	0.000134	CcSEcCtD
Vinorelbine—Vomiting—Gemcitabine—breast cancer	5.14e-06	0.000134	CcSEcCtD
Vinorelbine—Dyspnoea—Docetaxel—breast cancer	5.12e-06	0.000133	CcSEcCtD
Vinorelbine—Rash—Gemcitabine—breast cancer	5.1e-06	0.000133	CcSEcCtD
Vinorelbine—Dermatitis—Gemcitabine—breast cancer	5.09e-06	0.000133	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—breast cancer	5.07e-06	0.000132	CcSEcCtD
Vinorelbine—Erythema—Methotrexate—breast cancer	5.07e-06	0.000132	CcSEcCtD
Vinorelbine—Headache—Gemcitabine—breast cancer	5.07e-06	0.000132	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Capecitabine—breast cancer	5.06e-06	0.000132	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—breast cancer	5.06e-06	0.000132	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—breast cancer	5.06e-06	0.000132	CcSEcCtD
Vinorelbine—Vomiting—Fluorouracil—breast cancer	5.06e-06	0.000132	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—breast cancer	5.02e-06	0.000131	CcSEcCtD
Vinorelbine—Rash—Fluorouracil—breast cancer	5.01e-06	0.000131	CcSEcCtD
Vinorelbine—Dermatitis—Fluorouracil—breast cancer	5.01e-06	0.000131	CcSEcCtD
Vinorelbine—Paraesthesia—Capecitabine—breast cancer	4.99e-06	0.00013	CcSEcCtD
Vinorelbine—Decreased appetite—Docetaxel—breast cancer	4.99e-06	0.00013	CcSEcCtD
Vinorelbine—Hypersensitivity—Paclitaxel—breast cancer	4.99e-06	0.00013	CcSEcCtD
Vinorelbine—Headache—Fluorouracil—breast cancer	4.98e-06	0.00013	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Docetaxel—breast cancer	4.95e-06	0.000129	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—breast cancer	4.95e-06	0.000129	CcSEcCtD
Vinorelbine—Dyspnoea—Capecitabine—breast cancer	4.95e-06	0.000129	CcSEcCtD
Vinorelbine—Fatigue—Docetaxel—breast cancer	4.95e-06	0.000129	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—breast cancer	4.94e-06	0.000129	CcSEcCtD
Vinorelbine—Nausea—Irinotecan—breast cancer	4.93e-06	0.000129	CcSEcCtD
Vinorelbine—Nausea—Mitoxantrone—breast cancer	4.93e-06	0.000129	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—breast cancer	4.92e-06	0.000128	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—breast cancer	4.91e-06	0.000128	CcSEcCtD
Vinorelbine—Constipation—Docetaxel—breast cancer	4.91e-06	0.000128	CcSEcCtD
Vinorelbine—Pain—Docetaxel—breast cancer	4.91e-06	0.000128	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—breast cancer	4.9e-06	0.000128	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—breast cancer	4.87e-06	0.000127	CcSEcCtD
Vinorelbine—Asthenia—Paclitaxel—breast cancer	4.86e-06	0.000127	CcSEcCtD
Vinorelbine—Decreased appetite—Capecitabine—breast cancer	4.83e-06	0.000126	CcSEcCtD
Vinorelbine—Alopecia—Epirubicin—breast cancer	4.81e-06	0.000126	CcSEcCtD
Vinorelbine—Nausea—Gemcitabine—breast cancer	4.8e-06	0.000125	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Capecitabine—breast cancer	4.8e-06	0.000125	CcSEcCtD
Vinorelbine—Fatigue—Capecitabine—breast cancer	4.79e-06	0.000125	CcSEcCtD
Vinorelbine—Pruritus—Paclitaxel—breast cancer	4.79e-06	0.000125	CcSEcCtD
Vinorelbine—Pain—Capecitabine—breast cancer	4.75e-06	0.000124	CcSEcCtD
Vinorelbine—Constipation—Capecitabine—breast cancer	4.75e-06	0.000124	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—breast cancer	4.74e-06	0.000124	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—breast cancer	4.74e-06	0.000124	CcSEcCtD
Vinorelbine—Feeling abnormal—Docetaxel—breast cancer	4.73e-06	0.000123	CcSEcCtD
Vinorelbine—Nausea—Fluorouracil—breast cancer	4.72e-06	0.000123	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—breast cancer	4.7e-06	0.000123	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Docetaxel—breast cancer	4.69e-06	0.000122	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—breast cancer	4.68e-06	0.000122	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—breast cancer	4.68e-06	0.000122	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—breast cancer	4.68e-06	0.000122	CcSEcCtD
Vinorelbine—Diarrhoea—Paclitaxel—breast cancer	4.63e-06	0.000121	CcSEcCtD
Vinorelbine—Back pain—Epirubicin—breast cancer	4.59e-06	0.00012	CcSEcCtD
Vinorelbine—Feeling abnormal—Capecitabine—breast cancer	4.58e-06	0.000119	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—breast cancer	4.57e-06	0.000119	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—breast cancer	4.57e-06	0.000119	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—breast cancer	4.55e-06	0.000119	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—breast cancer	4.55e-06	0.000119	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Capecitabine—breast cancer	4.54e-06	0.000119	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—breast cancer	4.54e-06	0.000119	CcSEcCtD
Vinorelbine—Abdominal pain—Docetaxel—breast cancer	4.54e-06	0.000118	CcSEcCtD
Vinorelbine—Body temperature increased—Docetaxel—breast cancer	4.54e-06	0.000118	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—breast cancer	4.54e-06	0.000118	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—breast cancer	4.5e-06	0.000117	CcSEcCtD
Vinorelbine—Dizziness—Paclitaxel—breast cancer	4.48e-06	0.000117	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—breast cancer	4.46e-06	0.000116	CcSEcCtD
Vinorelbine—Cough—Methotrexate—breast cancer	4.42e-06	0.000115	CcSEcCtD
Vinorelbine—Urticaria—Capecitabine—breast cancer	4.41e-06	0.000115	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—breast cancer	4.4e-06	0.000115	CcSEcCtD
Vinorelbine—Abdominal pain—Capecitabine—breast cancer	4.39e-06	0.000115	CcSEcCtD
Vinorelbine—Body temperature increased—Capecitabine—breast cancer	4.39e-06	0.000115	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—breast cancer	4.39e-06	0.000114	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—breast cancer	4.39e-06	0.000114	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—breast cancer	4.38e-06	0.000114	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—breast cancer	4.32e-06	0.000113	CcSEcCtD
Vinorelbine—Chest pain—Methotrexate—breast cancer	4.32e-06	0.000113	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—breast cancer	4.32e-06	0.000113	CcSEcCtD
Vinorelbine—Vomiting—Paclitaxel—breast cancer	4.31e-06	0.000112	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.29e-06	0.000112	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—breast cancer	4.28e-06	0.000112	CcSEcCtD
Vinorelbine—Rash—Paclitaxel—breast cancer	4.27e-06	0.000111	CcSEcCtD
Vinorelbine—Dermatitis—Paclitaxel—breast cancer	4.27e-06	0.000111	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—breast cancer	4.26e-06	0.000111	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—breast cancer	4.26e-06	0.000111	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—breast cancer	4.25e-06	0.000111	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—breast cancer	4.25e-06	0.000111	CcSEcCtD
Vinorelbine—Headache—Paclitaxel—breast cancer	4.24e-06	0.000111	CcSEcCtD
Vinorelbine—Hypersensitivity—Docetaxel—breast cancer	4.23e-06	0.00011	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—breast cancer	4.19e-06	0.000109	CcSEcCtD
Vinorelbine—Cough—Epirubicin—breast cancer	4.14e-06	0.000108	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—breast cancer	4.14e-06	0.000108	CcSEcCtD
Vinorelbine—Asthenia—Docetaxel—breast cancer	4.12e-06	0.000107	CcSEcCtD
Vinorelbine—Infection—Methotrexate—breast cancer	4.11e-06	0.000107	CcSEcCtD
Vinorelbine—Hypertension—Epirubicin—breast cancer	4.1e-06	0.000107	CcSEcCtD
Vinorelbine—Hypersensitivity—Capecitabine—breast cancer	4.09e-06	0.000107	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—breast cancer	4.07e-06	0.000106	CcSEcCtD
Vinorelbine—Pruritus—Docetaxel—breast cancer	4.06e-06	0.000106	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—breast cancer	4.06e-06	0.000106	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—breast cancer	4.06e-06	0.000106	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—breast cancer	4.05e-06	0.000106	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—breast cancer	4.04e-06	0.000105	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—breast cancer	4.04e-06	0.000105	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—breast cancer	4.04e-06	0.000105	CcSEcCtD
Vinorelbine—Nausea—Paclitaxel—breast cancer	4.02e-06	0.000105	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—breast cancer	4.02e-06	0.000105	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.01e-06	0.000105	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—breast cancer	3.99e-06	0.000104	CcSEcCtD
Vinorelbine—Asthenia—Capecitabine—breast cancer	3.99e-06	0.000104	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—breast cancer	3.96e-06	0.000103	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—breast cancer	3.94e-06	0.000103	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—breast cancer	3.94e-06	0.000103	CcSEcCtD
Vinorelbine—Pruritus—Capecitabine—breast cancer	3.93e-06	0.000103	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—breast cancer	3.93e-06	0.000102	CcSEcCtD
Vinorelbine—Diarrhoea—Docetaxel—breast cancer	3.93e-06	0.000102	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—breast cancer	3.88e-06	0.000101	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—breast cancer	3.87e-06	0.000101	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—breast cancer	3.87e-06	0.000101	CcSEcCtD
Vinorelbine—Infection—Epirubicin—breast cancer	3.85e-06	0.0001	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—breast cancer	3.83e-06	9.99e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Capecitabine—breast cancer	3.8e-06	9.92e-05	CcSEcCtD
Vinorelbine—Nervous system disorder—Epirubicin—breast cancer	3.8e-06	9.9e-05	CcSEcCtD
Vinorelbine—Dizziness—Docetaxel—breast cancer	3.8e-06	9.9e-05	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—breast cancer	3.79e-06	9.89e-05	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—breast cancer	3.79e-06	9.88e-05	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—breast cancer	3.78e-06	9.85e-05	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.77e-06	9.83e-05	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—breast cancer	3.76e-06	9.81e-05	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—breast cancer	3.74e-06	9.75e-05	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—breast cancer	3.74e-06	9.75e-05	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—breast cancer	3.74e-06	9.75e-05	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—breast cancer	3.71e-06	9.69e-05	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.71e-06	9.68e-05	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—breast cancer	3.69e-06	9.63e-05	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—breast cancer	3.69e-06	9.62e-05	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—breast cancer	3.69e-06	9.62e-05	CcSEcCtD
Vinorelbine—Dizziness—Capecitabine—breast cancer	3.67e-06	9.58e-05	CcSEcCtD
Vinorelbine—Vomiting—Docetaxel—breast cancer	3.65e-06	9.52e-05	CcSEcCtD
Vinorelbine—Rash—Docetaxel—breast cancer	3.62e-06	9.44e-05	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—breast cancer	3.62e-06	9.43e-05	CcSEcCtD
Vinorelbine—Dermatitis—Docetaxel—breast cancer	3.62e-06	9.43e-05	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—breast cancer	3.6e-06	9.38e-05	CcSEcCtD
Vinorelbine—Headache—Docetaxel—breast cancer	3.6e-06	9.38e-05	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—breast cancer	3.58e-06	9.34e-05	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—breast cancer	3.57e-06	9.31e-05	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—breast cancer	3.57e-06	9.3e-05	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—breast cancer	3.56e-06	9.28e-05	CcSEcCtD
Vinorelbine—Pain—Methotrexate—breast cancer	3.54e-06	9.23e-05	CcSEcCtD
Vinorelbine—Vomiting—Capecitabine—breast cancer	3.53e-06	9.22e-05	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.53e-06	9.2e-05	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—breast cancer	3.51e-06	9.16e-05	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—breast cancer	3.51e-06	9.15e-05	CcSEcCtD
Vinorelbine—Rash—Capecitabine—breast cancer	3.5e-06	9.14e-05	CcSEcCtD
Vinorelbine—Dermatitis—Capecitabine—breast cancer	3.5e-06	9.13e-05	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—breast cancer	3.5e-06	9.12e-05	CcSEcCtD
Vinorelbine—Headache—Capecitabine—breast cancer	3.48e-06	9.08e-05	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—breast cancer	3.48e-06	9.07e-05	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—breast cancer	3.48e-06	9.07e-05	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—breast cancer	3.45e-06	9e-05	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—breast cancer	3.41e-06	8.91e-05	CcSEcCtD
Vinorelbine—Nausea—Docetaxel—breast cancer	3.41e-06	8.89e-05	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—breast cancer	3.41e-06	8.89e-05	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—breast cancer	3.38e-06	8.82e-05	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—breast cancer	3.37e-06	8.78e-05	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—breast cancer	3.35e-06	8.73e-05	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—breast cancer	3.34e-06	8.72e-05	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—breast cancer	3.34e-06	8.71e-05	CcSEcCtD
Vinorelbine—Pain—Epirubicin—breast cancer	3.31e-06	8.63e-05	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—breast cancer	3.31e-06	8.63e-05	CcSEcCtD
Vinorelbine—Nausea—Capecitabine—breast cancer	3.3e-06	8.61e-05	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—breast cancer	3.29e-06	8.57e-05	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—breast cancer	3.27e-06	8.53e-05	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—breast cancer	3.27e-06	8.53e-05	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.26e-06	8.51e-05	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—breast cancer	3.22e-06	8.39e-05	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—breast cancer	3.19e-06	8.33e-05	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—breast cancer	3.19e-06	8.32e-05	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Epirubicin—breast cancer	3.17e-06	8.26e-05	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—breast cancer	3.11e-06	8.12e-05	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.09e-06	8.07e-05	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—breast cancer	3.09e-06	8.05e-05	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—breast cancer	3.08e-06	8.02e-05	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—breast cancer	3.06e-06	7.99e-05	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—breast cancer	3.06e-06	7.99e-05	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—breast cancer	3.06e-06	7.98e-05	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—breast cancer	3.06e-06	7.98e-05	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—breast cancer	3.05e-06	7.95e-05	CcSEcCtD
Vinorelbine—Asthenia—Methotrexate—breast cancer	2.97e-06	7.74e-05	CcSEcCtD
Vinorelbine—Feeling abnormal—Doxorubicin—breast cancer	2.95e-06	7.7e-05	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—breast cancer	2.93e-06	7.64e-05	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—breast cancer	2.93e-06	7.63e-05	CcSEcCtD
Vinorelbine—Hypersensitivity—Epirubicin—breast cancer	2.85e-06	7.44e-05	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—breast cancer	2.85e-06	7.42e-05	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—breast cancer	2.83e-06	7.39e-05	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—breast cancer	2.83e-06	7.39e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Methotrexate—breast cancer	2.83e-06	7.38e-05	CcSEcCtD
Vinorelbine—Asthenia—Epirubicin—breast cancer	2.78e-06	7.24e-05	CcSEcCtD
Vinorelbine—Pruritus—Epirubicin—breast cancer	2.74e-06	7.14e-05	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—breast cancer	2.74e-06	7.13e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Epirubicin—breast cancer	2.65e-06	6.91e-05	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—breast cancer	2.64e-06	6.88e-05	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—breast cancer	2.63e-06	6.86e-05	CcSEcCtD
Vinorelbine—Rash—Methotrexate—breast cancer	2.61e-06	6.8e-05	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—breast cancer	2.61e-06	6.8e-05	CcSEcCtD
Vinorelbine—Headache—Methotrexate—breast cancer	2.59e-06	6.76e-05	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—breast cancer	2.57e-06	6.7e-05	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—breast cancer	2.56e-06	6.68e-05	CcSEcCtD
Vinorelbine—Pruritus—Doxorubicin—breast cancer	2.53e-06	6.61e-05	CcSEcCtD
Vinorelbine—Vomiting—Epirubicin—breast cancer	2.46e-06	6.42e-05	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—breast cancer	2.46e-06	6.41e-05	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—breast cancer	2.45e-06	6.39e-05	CcSEcCtD
Vinorelbine—Rash—Epirubicin—breast cancer	2.44e-06	6.37e-05	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—breast cancer	2.44e-06	6.36e-05	CcSEcCtD
Vinorelbine—Headache—Epirubicin—breast cancer	2.43e-06	6.33e-05	CcSEcCtD
Vinorelbine—Dizziness—Doxorubicin—breast cancer	2.37e-06	6.18e-05	CcSEcCtD
Vinorelbine—Nausea—Epirubicin—breast cancer	2.3e-06	6e-05	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—breast cancer	2.28e-06	5.94e-05	CcSEcCtD
Vinorelbine—Rash—Doxorubicin—breast cancer	2.26e-06	5.89e-05	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—breast cancer	2.26e-06	5.89e-05	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—breast cancer	2.24e-06	5.85e-05	CcSEcCtD
Vinorelbine—Nausea—Doxorubicin—breast cancer	2.13e-06	5.55e-05	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.08e-06	5.4e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HADHB—breast cancer	1.08e-06	5.39e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPI—breast cancer	1.08e-06	5.39e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.06e-06	5.28e-05	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—breast cancer	1.05e-06	5.25e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—FHL2—breast cancer	1.05e-06	5.23e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ADSL—breast cancer	1.05e-06	5.23e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NME1—breast cancer	1.05e-06	5.23e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PHGDH—breast cancer	1.05e-06	5.23e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—UMPS—breast cancer	1.05e-06	5.23e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NDUFS3—breast cancer	1.04e-06	5.21e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.04e-06	5.2e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALDH1A1—breast cancer	1.03e-06	5.14e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALDH7A1—breast cancer	1.03e-06	5.14e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LDHB—breast cancer	1.03e-06	5.13e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—BRIP1—breast cancer	1.03e-06	5.13e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HPSE—breast cancer	1.03e-06	5.13e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.01e-06	5.07e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1e-06	5.01e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ADSL—breast cancer	9.85e-07	4.93e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NME1—breast cancer	9.85e-07	4.93e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—FHL2—breast cancer	9.85e-07	4.93e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PHGDH—breast cancer	9.85e-07	4.93e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—UMPS—breast cancer	9.85e-07	4.93e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CHST9—breast cancer	9.8e-07	4.9e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	9.75e-07	4.87e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCC1—breast cancer	9.72e-07	4.86e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA3—breast cancer	9.72e-07	4.86e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HMMR—breast cancer	9.72e-07	4.86e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LDHB—breast cancer	9.66e-07	4.83e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—BRIP1—breast cancer	9.66e-07	4.83e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HPSE—breast cancer	9.66e-07	4.83e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPARGC1B—breast cancer	9.41e-07	4.71e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	9.35e-07	4.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—COX11—breast cancer	9.29e-07	4.65e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	9.22e-07	4.61e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCC1—breast cancer	9.16e-07	4.58e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA3—breast cancer	9.16e-07	4.58e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HMMR—breast cancer	9.16e-07	4.58e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	8.97e-07	4.49e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	8.95e-07	4.47e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA9—breast cancer	8.89e-07	4.45e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA4—breast cancer	8.89e-07	4.45e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPARGC1B—breast cancer	8.87e-07	4.44e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	8.77e-07	4.39e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA2—breast cancer	8.66e-07	4.33e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GPX2—breast cancer	8.66e-07	4.33e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GPX4—breast cancer	8.56e-07	4.28e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SULT1A1—breast cancer	8.56e-07	4.28e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CDA—breast cancer	8.5e-07	4.25e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SHMT1—breast cancer	8.5e-07	4.25e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA4—breast cancer	8.38e-07	4.19e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA9—breast cancer	8.38e-07	4.19e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTA1—breast cancer	8.36e-07	4.18e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—IDH1—breast cancer	8.36e-07	4.18e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	8.35e-07	4.18e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	8.29e-07	4.14e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NAT2—breast cancer	8.27e-07	4.13e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC2A5—breast cancer	8.18e-07	4.09e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLCO1B1—breast cancer	8.18e-07	4.09e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA2—breast cancer	8.16e-07	4.08e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPX2—breast cancer	8.16e-07	4.08e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SULT1A1—breast cancer	8.06e-07	4.03e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPX4—breast cancer	8.06e-07	4.03e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APRT—breast cancer	7.9e-07	3.95e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—IDH1—breast cancer	7.88e-07	3.94e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTA1—breast cancer	7.88e-07	3.94e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NAT2—breast cancer	7.79e-07	3.9e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	7.61e-07	3.81e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ESRRA—breast cancer	7.43e-07	3.72e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ANGPTL4—breast cancer	7.43e-07	3.72e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	7.37e-07	3.68e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MED12—breast cancer	7.25e-07	3.62e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—DPYD—breast cancer	7.25e-07	3.62e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALDOA—breast cancer	7.13e-07	3.57e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPI—breast cancer	7.04e-07	3.52e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HADHB—breast cancer	7.04e-07	3.52e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOA3—breast cancer	6.93e-07	3.46e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC2A2—breast cancer	6.88e-07	3.44e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MED12—breast cancer	6.83e-07	3.42e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—DPYD—breast cancer	6.83e-07	3.42e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCG2—breast cancer	6.74e-07	3.37e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTR—breast cancer	6.74e-07	3.37e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CPT1A—breast cancer	6.74e-07	3.37e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALDOA—breast cancer	6.72e-07	3.36e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALDH7A1—breast cancer	6.72e-07	3.36e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALDH1A1—breast cancer	6.72e-07	3.36e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HPGDS—breast cancer	6.61e-07	3.3e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HBA1—breast cancer	6.57e-07	3.28e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOA3—breast cancer	6.53e-07	3.26e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC2A2—breast cancer	6.48e-07	3.24e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NME1—breast cancer	6.44e-07	3.22e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ADSL—breast cancer	6.44e-07	3.22e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—FHL2—breast cancer	6.44e-07	3.22e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—UMPS—breast cancer	6.44e-07	3.22e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PHGDH—breast cancer	6.44e-07	3.22e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ACHE—breast cancer	6.41e-07	3.21e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTT1—breast cancer	6.41e-07	3.21e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTR—breast cancer	6.35e-07	3.18e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCG2—breast cancer	6.35e-07	3.18e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CPT1A—breast cancer	6.35e-07	3.18e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HPSE—breast cancer	6.32e-07	3.16e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LDHB—breast cancer	6.32e-07	3.16e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—BRIP1—breast cancer	6.32e-07	3.16e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HPGDS—breast cancer	6.23e-07	3.11e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	6.22e-07	3.11e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HBA1—breast cancer	6.19e-07	3.09e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP17A1—breast cancer	6.07e-07	3.03e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ACHE—breast cancer	6.04e-07	3.02e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTT1—breast cancer	6.04e-07	3.02e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ENO1—breast cancer	6.01e-07	3e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS1—breast cancer	6.01e-07	3e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA3—breast cancer	5.99e-07	3e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HMMR—breast cancer	5.99e-07	3e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCC1—breast cancer	5.99e-07	3e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP2D6—breast cancer	5.89e-07	2.95e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.8e-07	2.9e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOA2—breast cancer	5.78e-07	2.89e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP17A1—breast cancer	5.72e-07	2.86e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ENO1—breast cancer	5.66e-07	2.83e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS1—breast cancer	5.66e-07	2.83e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	5.62e-07	2.81e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—FASN—breast cancer	5.61e-07	2.8e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—BCHE—breast cancer	5.58e-07	2.79e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC5A5—breast cancer	5.51e-07	2.76e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA4—breast cancer	5.48e-07	2.74e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA9—breast cancer	5.48e-07	2.74e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOA2—breast cancer	5.45e-07	2.72e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA2—breast cancer	5.34e-07	2.67e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPX2—breast cancer	5.34e-07	2.67e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NQO1—breast cancer	5.33e-07	2.66e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC2A1—breast cancer	5.33e-07	2.66e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—FASN—breast cancer	5.28e-07	2.64e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPX4—breast cancer	5.27e-07	2.64e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SULT1A1—breast cancer	5.27e-07	2.64e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—BCHE—breast cancer	5.26e-07	2.63e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC5A5—breast cancer	5.2e-07	2.6e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP3A4—breast cancer	5.19e-07	2.6e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—IDH1—breast cancer	5.15e-07	2.58e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTA1—breast cancer	5.15e-07	2.58e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1B1—breast cancer	5.11e-07	2.55e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NAT2—breast cancer	5.09e-07	2.55e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5.08e-07	2.54e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC2A1—breast cancer	5.02e-07	2.51e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NQO1—breast cancer	5.02e-07	2.51e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HSP90AA1—breast cancer	5.01e-07	2.5e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP3A4—breast cancer	4.89e-07	2.45e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOA1—breast cancer	4.87e-07	2.44e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1B1—breast cancer	4.81e-07	2.41e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—STK11—breast cancer	4.8e-07	2.4e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP19A1—breast cancer	4.8e-07	2.4e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.72e-07	2.36e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOA1—breast cancer	4.59e-07	2.3e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—STK11—breast cancer	4.52e-07	2.26e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP19A1—breast cancer	4.52e-07	2.26e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MED12—breast cancer	4.47e-07	2.23e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—DPYD—breast cancer	4.47e-07	2.23e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—COMT—breast cancer	4.46e-07	2.23e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTP1—breast cancer	4.44e-07	2.22e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALDOA—breast cancer	4.4e-07	2.2e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HMOX1—breast cancer	4.38e-07	2.19e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ITPR1—breast cancer	4.37e-07	2.19e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOA3—breast cancer	4.27e-07	2.13e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC2A2—breast cancer	4.24e-07	2.12e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—COMT—breast cancer	4.21e-07	2.1e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTP1—breast cancer	4.19e-07	2.09e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTR—breast cancer	4.15e-07	2.08e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CPT1A—breast cancer	4.15e-07	2.08e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCG2—breast cancer	4.15e-07	2.08e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TYMS—breast cancer	4.13e-07	2.07e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HMOX1—breast cancer	4.13e-07	2.06e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ITPR1—breast cancer	4.12e-07	2.06e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOR1—breast cancer	4.08e-07	2.04e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PLA2G4A—breast cancer	4.08e-07	2.04e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTM1—breast cancer	4.08e-07	2.04e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HPGDS—breast cancer	4.07e-07	2.04e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HBA1—breast cancer	4.05e-07	2.02e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCB1—breast cancer	3.96e-07	1.98e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ACHE—breast cancer	3.95e-07	1.97e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTT1—breast cancer	3.95e-07	1.97e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GPX1—breast cancer	3.91e-07	1.96e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TYMS—breast cancer	3.89e-07	1.95e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1A1—breast cancer	3.87e-07	1.94e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.85e-07	1.92e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOR1—breast cancer	3.85e-07	1.92e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTM1—breast cancer	3.85e-07	1.92e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ERCC2—breast cancer	3.84e-07	1.92e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP17A1—breast cancer	3.74e-07	1.87e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS1—breast cancer	3.7e-07	1.85e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ENO1—breast cancer	3.7e-07	1.85e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPX1—breast cancer	3.68e-07	1.84e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1A1—breast cancer	3.65e-07	1.82e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP2D6—breast cancer	3.63e-07	1.81e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ERCC2—breast cancer	3.62e-07	1.81e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTHFR—breast cancer	3.61e-07	1.8e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOA2—breast cancer	3.56e-07	1.78e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—FASN—breast cancer	3.45e-07	1.73e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—BCHE—breast cancer	3.44e-07	1.72e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTHFR—breast cancer	3.4e-07	1.7e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC5A5—breast cancer	3.4e-07	1.7e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CAV1—breast cancer	3.33e-07	1.66e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NQO1—breast cancer	3.28e-07	1.64e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC2A1—breast cancer	3.28e-07	1.64e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1B1—breast cancer	3.15e-07	1.57e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CAV1—breast cancer	3.14e-07	1.57e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.09e-07	1.54e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CG—breast cancer	3.03e-07	1.52e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOA1—breast cancer	3e-07	1.5e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—STK11—breast cancer	2.96e-07	1.48e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP19A1—breast cancer	2.96e-07	1.48e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.86e-07	1.43e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—COMT—breast cancer	2.75e-07	1.38e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTP1—breast cancer	2.74e-07	1.37e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HMOX1—breast cancer	2.7e-07	1.35e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ITPR1—breast cancer	2.69e-07	1.35e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CD—breast cancer	2.66e-07	1.33e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALB—breast cancer	2.63e-07	1.32e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCB1—breast cancer	2.59e-07	1.3e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TYMS—breast cancer	2.54e-07	1.27e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NOS3—breast cancer	2.52e-07	1.26e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.52e-07	1.26e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOR1—breast cancer	2.52e-07	1.26e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM1—breast cancer	2.52e-07	1.26e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.51e-07	1.26e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALB—breast cancer	2.48e-07	1.24e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPX1—breast cancer	2.41e-07	1.2e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.38e-07	1.19e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NOS3—breast cancer	2.37e-07	1.19e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ERCC2—breast cancer	2.36e-07	1.18e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CB—breast cancer	2.32e-07	1.16e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—breast cancer	2.3e-07	1.15e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTHFR—breast cancer	2.22e-07	1.11e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.19e-07	1.09e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—breast cancer	2.17e-07	1.08e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CAV1—breast cancer	2.05e-07	1.03e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTEN—breast cancer	2.01e-07	1e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTEN—breast cancer	1.89e-07	9.46e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.87e-07	9.34e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.64e-07	8.21e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALB—breast cancer	1.62e-07	8.11e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NOS3—breast cancer	1.55e-07	7.75e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.43e-07	7.16e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—breast cancer	1.42e-07	7.09e-06	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CA—breast cancer	1.42e-07	7.08e-06	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.33e-07	6.67e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTEN—breast cancer	1.24e-07	6.18e-06	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—breast cancer	1.16e-07	5.78e-06	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—breast cancer	1.09e-07	5.45e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CA—breast cancer	8.72e-08	4.36e-06	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—breast cancer	7.13e-08	3.56e-06	CbGpPWpGaD
